1. Department of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT, USA;
2. Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA;
3. CIBERONC, Instituto Carlos III, Madrid, Spain;
4. Hematology Department, Saint-Louis Hospital AP-HP, Paris, France;
5. Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany;
6. Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA;
7. Leukemia Program, Cleveland Clinic, Cleveland, OH, USA;
8. Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA;
9. Indiana University Simon Cancer Center, Indianapolis, IN, USA;
10. Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA;
11. University of Illinois Cancer Center, Chicago, IL, USA;
12. Weill Cornell Medicine, The New York Presbyterian Hospital, New York, NY, USA;
13. CHU of Nice, Hematology Department, Cote d’Azur University, Nice, France;
14. University of North Carolina Physician Network, Rocky Mount, NC, USA;
15. University Clinical Hospital, INCLIVA, Valencia, Spain